Classon; Brendan J.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Classon; Brendan J..The latest application filed is for "methods for treating eosinophilic esophagitis by administering an il-4r inhibitor".

Company Profile

2.9.8

Classon; Brendan J. - Seattle WA
Classon; Brendan J. - Arlington MA
Classon; Brendan J. - Ridgefield CT US

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Methods of treating eosinophilic esophagitis by administering an antibody which inhibits interleukin-4 receptor (IL-4R) Grant 11,421,036 - Kostic , et al. August 23, 2	2022-08-23
Methods For Treating Eosinophilic Esophagitis By Administering An Il-4r Inhibitor App 20200332014 - KOSTIC; Ana ; et al.	2020-10-22
Methods for treating eosinophilic esophagitis by administering an IL-4R inhibitor Grant 10,730,948 - Kostic , et al.	2020-08-04
Human Antibodies To Human Tnf-like Ligand 1a (tl1a) App 20170096491 - Classon; Brendan J. ; et al.	2017-04-06
Method of treating a TL1A-associated disease or disorder with human antibodies to TL1A Grant 9,556,277 - Classon , et al. January 31, 2	2017-01-31
Methods of treating systemic lupus erythematosus (SLE) using anti-CD48 antibodies Grant 9,533,039 - Classon , et al. January 3, 2	2017-01-03
Methods for treating eosinophilic esophagitis by administering an IL-4R inhibitor App 20160152718 - Kostic; Ana ; et al.	2016-06-02
Methods for treating eosinophilic esophagitis by administering an IL-4R inhibitor Grant 9,290,574 - Kostic , et al. March 22, 2	2016-03-22
Antibodies capable of blocking the interaction between CD48 and a CD48 receptor Grant 9,228,014 - Classon , et al. January 5, 2	2016-01-05
Methods For Treating Eosinophilic Esophagitis By Administering An Il-4r Inhibitor App 20150017176 - KOSTIC; Ana ; et al.	2015-01-15
Human Antibodies to Human TNF-Like Ligand 1A (TL1A) App 20140120109 - Classon; Brendan J. ; et al.	2014-05-01
Human antibodies to human TNF-like ligand 1A (TL1A) Grant 8,642,741 - Classon , et al. February 4, 2	2014-02-04
Methods Of Treating Systemic Lupus Erythematosus (sle) Using Anti-cd48 Antibodies App 20130230533 - CLASSON; BRENDAN J. ; et al.	2013-09-05
Human Antibodies To Human Tnf-like Ligand 1a (tl1a) App 20120114654 - Classon; Brendan J. ; et al.	2012-05-10
Anti-cd48 Antibodies And Uses Thereof App 20120076790 - CLASSON; Brendan J. ; et al.	2012-03-29

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.